<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="168141">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01874899</url>
  </required_header>
  <id_info>
    <org_study_id>JPNI-3</org_study_id>
    <nct_id>NCT01874899</nct_id>
  </id_info>
  <brief_title>Prospective Randomized Feasibility Study Comparing Manual vs. Automatic Position-Adaptive Spinal Cord Stimulation With Surgical Leads</brief_title>
  <acronym>RestoreSensor</acronym>
  <official_title>Prospective Randomized Feasibility Study Comparing Manual vs. Automatic Position-Adaptive Spinal Cord Stimulation With Surgical Leads</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Justin Parker Neurological Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Justin Parker Neurological Institute</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main purpose of this study is to establish the extent that chronic pain patients
      implanted with surgical, laminectomy-type, leads experience position-related variation in
      spinal cord stimulation therapy and to investigate the effects of manual versus automatic
      position-adaptive spinal cord stimulation on clinical outcome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A single-center, prospective, randomized study with a two-arm crossover design. The primary
      objective of this study is to establish threshold and therapeutic stimulation parameters for
      the RestoreSensor neurostimulator in response to postural changes. The secondary objective
      is to compare the effectiveness of spinal cord stimulation with manual versus automatic
      position-adaptive settings for chronic refractory low back and/or extremity pain.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">June 2014</completion_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Stimulation amplitude changes  in response to postural changes</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Threshold and therapeutic stimulation parameters in different postures: lying right, lying left, lying prone, lying supine, upright and upright active will be collected for manual and sensor-driven position-adaptive stimulation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sleep quality improvement</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Pittsburg Sleep Quality Index Oswestry Disability Index</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Disability score improvement</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Oswestry Disability Index</description>
  </other_outcome>
  <other_outcome>
    <measure>Pain scores</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Numeric pain scale</description>
  </other_outcome>
  <other_outcome>
    <measure>Patient satisfaction</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Likert scale</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Chronic Refractory Low Back and Leg Pain</condition>
  <arm_group>
    <arm_group_label>Manual, then Automatic Stimulation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The RestoreSensor neurostimulator will be programed for manual stimulation adjustments and the patients will crossover to automatic stimulation group after 1.5 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Automatic, then Manual Stimulation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The RestoreSensor neurostimulator will be programed for automatic stimulation adjustments and the patients will crossover to manual stimulation group after 1.5 months.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>RestoreSensor Neurostimulation</intervention_name>
    <arm_group_label>Manual, then Automatic Stimulation</arm_group_label>
    <arm_group_label>Automatic, then Manual Stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Skeletally mature adults between 18 and 70 years old

          -  Patients with chronic refractory back and/or leg pain associated with failed back
             surgery syndrome, post-laminectomy pain, radicular pain syndrome or radiculopathy
             refractory to conservative and surgical interventions

          -  &gt; 50% pain reduction during the trail period

          -  Willing and able to comply with the requirements of the protocol including follow-up
             requirements

          -  Willing to sign a study specific informed consent

        Exclusion Criteria:

          -  Previous SCS treatment

          -  Surgically remediable spinal condition

          -  Active local or systemic infection
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kara Beasley, DO</last_name>
    <role>Principal Investigator</role>
    <affiliation>Boulder Neurosurgical Associates</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sigita Burneikiene</last_name>
    <phone>303-938-5700</phone>
    <email>sigitab@bnasurg.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Boulder Neurosurgical Associates</name>
      <address>
        <city>Boulder</city>
        <state>Colorado</state>
        <zip>80302</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sigita Burneikiene</last_name>
      <phone>303-938-5700</phone>
    </contact>
    <investigator>
      <last_name>E Lee Nelson, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <lastchanged_date>June 7, 2013</lastchanged_date>
  <firstreceived_date>June 6, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Justin Parker Neurological Institute</investigator_affiliation>
    <investigator_full_name>Alan T. Villavicencio, MD</investigator_full_name>
    <investigator_title>Principle Investigator</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
